The 2020 Progenitor Cell Translation Consortium (PCTC) Cardiovascular Bioengineering (CVBE) Symposium co-hosted by the UAB Department of Biomedical Engineering, will feature a keynote address by Victor Dzau, M.D., president of the National Academy of Medicine. Dzau, a professor of Medicine at Duke University will speak on “The Future of Heart Failure Therapy/Paracrine Mechanism of Stem Cell Therapy,” on December 5, 2020 at 9:10 a.m.

dzauSource: medicine.duke.eduDue to the worldwide outbreak of coronavirus (COVID-19), the symposium will be held in a virtual format via Zoom for the first time. The event was originally scheduled for the spring in Göttingen, Germany, and was anticipated to draw speakers and guests from around the globe. This collaborative conference, focusing on cardiac gene and cell therapy topics, is co-hosted and co-organized by UAB BME Chair Jay Zhang, M.D., Ph.D., and Wolfram Zimmerman, Ph.D., of the University Medical Center Göttingen. Topics addressed will include areas of gene editing, induced pluripotent stem cells, cardiac stem cells in the context of heart failure, cardiovascular bioengineering, vascular tissue engineering, cardiac development, exosomes, microRNAs, and mitochondria.

In addition to his role of president of the National Academy of Medicine (NAM) (formerly the Institute of Medicine), Dzau also serves as the vice chair of the National Research Council and is chancellor emeritus and James B. Duke Professor of Medicine at Duke University Health System. Prior to these roles, he was the Hersey Professor of Theory and Practice of Medicine and Chairman of Medicine at Harvard Medical School’s Brigham and Women’s Hospital, and Chairman of the Department of Medicine and Director of the Falk Cardiovascular Research Center at Stanford University. Dzau is a prominent world health leader and advises governments, corporations, and universities worldwide. He has also made a major impact on health and medicine through his seminal research in cardiovascular medicine and genetics and his leadership in health innovation.

Registration is free, but will be required for access to the symposium. Register online at: https://translationalcells.org/content/pctc-cardiovascular-bioengineering-cvbe-symposium

More News

Small giving, large impact

Small giving, large impact

Gifts of amounts as much as $1,000 can make a tremendous impact in the life of a student in need, and one UAB donor is working to make that a reality.

Read More
Materials engineering team develops process to make implants safer

Materials engineering team develops process to make implants safer

An interdisciplinary team of researchers at UAB has developed a new plasma-enabled process that could limit the proliferation of toxins from implants into a patient’s bloodstream. The team, led by Vinoy Thomas, Ph.D., associate professor in the Department of Mechanical and Materials Engineering (MME), recently published its findings in ACS Applied Materials & Interfaces.

Read More
Millen, Newman earn SMART Scholarships from the U.S. Department of Defense

Millen, Newman earn SMART Scholarships from the U.S. Department of Defense

Engineering students Nicholas Millen and Zachary Newman have each been awarded a Science, Mathematics, and Research for Transformation (SMART) Scholarship by the U.S. Department of Defense. The awards will provide the students with full tuition for up to five years, in addition to mentorship, summer internships, a stipend, and full-time employment after graduation.

Read More